As assessed by both weight change and pathological analysis, while WT Tregs were capable of mitigating colitis in recipients, mice receiving CD147-deficient Tregs developed colitis symptoms, including weight loss (Fig. 1B), massive leukocyte infiltration, and severe mucosal tissue damage in the colon (Fig. 1C, D). Here, BSG is linked to colitis.